Hypothyroidism, Metabolism and Food Intake
NCT02993562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2018-11-06
Summary
This project has the following primary aims:
To measure changes in appetite and food intake in newly diagnosed hypothyroid patients during the first six months after starting levothyroxine (L-T4) substitution therapy
Secondary aims are:
To delineate the effect of L-T4 substitution therapy on thyroid status, body weight, body mass index (BMI), body composition, physical activity, glycaemic control, postprandial gut and pancreatic hormone responses, gastric and gall bladder emptying, resting energy expenditure (REE), quality of life (QOL) and cognitive function
Conditions
Interventions
- DRUG
-
Levothyroxine
Normal treatment with levothyroxine.
Sponsors & Collaborators
-
Center for Diabetes Research, Herlev and Gentofte Hospital.
collaborator UNKNOWN -
Herlev Hospital
lead OTHER
Principal Investigators
-
Bjarke B Medici, MD · Department of Internal Medicine, Herlev and Gentofte hospitals.
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2018-08-30
- Completion
- 2018-08-30
Countries
- Denmark
Study Locations
More Related Trials
-
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
NCT00565864 ·Status: COMPLETED ·Phase: PHASE4
-
Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism
NCT02317926 ·Status: UNKNOWN ·Phase: NA
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4
-
Recovery Rate in Secondary Hypothyroidism
NCT05276856 ·Status: RECRUITING
-
Identification of Non-responders to Levothyroxine Therapy
NCT03627611 ·Status: COMPLETED ·Phase: PHASE2
-
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
NCT02577367 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
NCT01831869 ·Status: UNKNOWN ·Phase: PHASE4
-
Energy Metabolism in Thyroidectomized Patients
NCT04782856 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue
NCT02133040 ·Status: UNKNOWN
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism
NCT02917863 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Evening Versus Morning Levothyroxine Intake in Elderly
NCT03614988 ·Status: UNKNOWN ·Phase: NA
-
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism
NCT00531713 ·Status: COMPLETED ·Phase: PHASE4
-
Central Hypothyroidism and Cardiovascular Risk
NCT01574859 ·Status: COMPLETED
-
Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
NCT06083636 ·Status: RECRUITING
-
Central Hypothyroidism, a Novel Laboratory Measurement
NCT01280292 ·Status: UNKNOWN ·Phase: NA
-
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171 ·Status: UNKNOWN ·Phase: PHASE4
-
Levothyroxine Treatment in Thyroid Benign Nodular Goiter
NCT00552253 ·Status: COMPLETED ·Phase: NA
-
Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism
NCT02467244 ·Status: COMPLETED
-
Patient-centered Dosage of Levothyroxine
NCT06455371 ·Status: RECRUITING ·Phase: NA
-
Metabolomics of Thyroid Hormones
NCT03823859 ·Status: COMPLETED
-
Effect of Hypothyroidism on Brown Adipose Tissue
NCT02364102 ·Status: COMPLETED
-
Effects of L-carnitine on Hypothyroidism
NCT01769157 ·Status: COMPLETED ·Phase: PHASE4
-
Early Levothyroxine Post Radioactive Iodine
NCT01950260 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism
NCT02094079 ·Status: COMPLETED